The global Primary Biliary Cholangitis (PBC) market is witnessing significant growth due to the increasing prevalence of autoimmune liver diseases, advancements in diagnostic technologies, and the growing adoption of targeted therapeutics. Healthcare providers and pharmaceutical companies are focusing on innovative treatment approaches to improve disease management and patient outcomes. The...